Nevertheless, extending these observations to animal models of myocardial fibrosis associated with HF or diabetes is strongly recommended to place TRPM7 among the novel molecular targets to treat fibrosis-associated cardiac disorders. This evidence concerns the gene TRPM7 and Myocardial fibrosis.